Dr.Seek
Mobile health platform for doctor-patient communication
About Dr.Seek
Dr. Seek (tiexinyisheng.com), developed by Zhongkang Shangde Health Management (Beijing) Co., Ltd., is a mobile application designed to facilitate communication between doctors and patients. The company, formally known as Zhongkang Shangde Technology (Beijing) Co., Ltd., was established on June 9, 2014. Its legal representative is Yan Zhiming.
The platform operates as a patient follow-up and consultation tool for physicians, aiming to create a more precise matching system between doctors and patients based on established trust. The business provides services that include health consulting (excluding diagnosis), software development, and technical services. Dr. Seek's offerings extend to international medical services, such as arranging medical examinations in Japan, fertility assistance like egg freezing, and access to overseas medical treatments.
The company's business scope also covers the sale of Type I and Type II medical devices, AI application software development, and information system integration services. It targets a market seeking comprehensive health management solutions, from digital communication tools to international healthcare facilitation.
Source: Dealroom company dataAt a glance
- Founded
- 2013
- Headquarters
- Changping District, China
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Jiangsu Skyray Instrument
Winning Health Technology Group
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Dr.Seek on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Dr.Seek on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.